Population-Based Cancer Epidemiology of Sikkim, India: Incidence Patterns, Demographic Distribution, and Public Health Implications

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 3 | 02 | Page :
By

Tshetiz Dahal,

Kaveri Thapa,

  1. *1 General Physician and Clinical Researcher, Department of Medicine and Surgery Lugansk State Medical University, Lypnia St. Rivne,, Ukraine
  2. 2 Associate Professor and Senior Consultant,, Department of Dermatology, Helen Lepcha Sikkim government medical college, Sir Thutob Namgyal Memorial Hospital,, Gangtok, Sikkim

Abstract

Background: Cancer incidence in India shows marked regional variation due to differences in ethnicity, lifestyle, environmental exposure, and healthcare access. Sikkim, a small Himalayan state with unique demographic characteristics, has been covered by a Population- Based Cancer Registry (PBCR) under the National Cancer Registry Programme (NCRP), yet detailed analytical interpretations remain limited. Objectives: To conduct an in-depth epidemiological analysis of cancer incidence in Sikkim using PBCR data, examining site- specific patterns, age–sex distribution, and potential etiological and health-system determinants. Methods: Secondary analysis of published PBCR data (2003–2008) from Sikkim was performed. Crude incidence rates (CR), age-adjusted incidence rates (AAR), proportional site distribution, and age-specific trends were analyzed. Comparative interpretation with national estimates from NCRP, GLOBOCAN, and IJMR projections was undertaken. Descriptive statistical analysis and epidemiological inference were applied. Results: A total of 2,211 cancer cases were registered, with females exhibiting a higher AAR (99.4/100,000) than males (89.4/100,000). Leading cancers in males were stomach (15.0%), oesophagus (10.0%), and lung, while cervical cancer (11.7%) and breast cancer (9.1%) dominated female incidence. Upper gastrointestinal malignancies constituted a disproportionately high burden compared to national averages. Cancer incidence increased sharply after 45 years of age. Ethnic variation suggested higher incidence among Bhutia and Rai populations. Conclusion: Cancer patterns in Sikkim differ significantly from mainland India, emphasising cervical, gastric, and oesophageal cancers. Targeted screening, lifestyle interventions, and strengthening regional oncology infrastructure are urgently required.

Keywords: Cancer epidemiology; Population-based cancer registry; Sikkim; Incidence; India

How to cite this article: Tshetiz Dahal, Kaveri Thapa. Population-Based Cancer Epidemiology of Sikkim, India: Incidence Patterns, Demographic Distribution, and Public Health Implications. International Journal of Pathogens. 2026; 03(02):-.
How to cite this URL: Tshetiz Dahal, Kaveri Thapa. Population-Based Cancer Epidemiology of Sikkim, India: Incidence Patterns, Demographic Distribution, and Public Health Implications. International Journal of Pathogens. 2026; 03(02):-. Available from: https://journals.stmjournals.com/ijpg/article=2026/view=259564

References

Asthana S, Labani PS, Labani S. A review on cancer incidence in India from 25 population-based cancer registries. Journal of Dr. YSR University of Health Sciences. 2015 Jul 1;4(3):150-4. 2. Verma Y, Pradhan PK, Gurung N, Sapkota SD, Giri P, Sundas P, Bhattarai BN, Nadayil D, Ramnath T, Nandakumar A. Population-based cancer incidence in Sikkim, India: report on ethnic variation. British journal of cancer. 2012 Feb;106(5):962-5. 3. Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS, Icmr-Ncdir-Ncrp Investigator Group. Cancer statistics, 2020: report from national cancer registry programme, India. JCO global oncology. 2020 Jul;6:1063-75. 4. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021 May;71(3):209-49. 5. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015 Mar;65(2):87-108. 6. Bray F, Møller B. Predicting the future burden of cancer. Nature Reviews Cancer. 2006 Jan 1;6(1):63-74. 7. Adenis A, Dufit V, Douine M, Najioullah F, Molinie V, Catherine D, Kilié O, Thomas N, Deshayes JL, Brousse P, Amor HB. The singular epidemiology of HPV infection among French Guianese women with normal cytology. BMC Public Health. 2017 Mar 24;17(1):279. 8. Tung EK, Wong CM, Yau TO, Lee JM, Ching YP, Ng IO. HAI‐2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti‐invasive functions. International journal of cancer. 2009 Apr 15;124(8):1811-9. 9. Pimple S, Mishra G, Shastri S. Global strategies for cervical cancer prevention. Current Opinion in Obstetrics and Gynecology. 2016 Feb 1;28(1):4-10. 10. Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, Kumar R, Roy S, Suraweera W, Bray F, Mallath M. Cancer mortality in India: a nationally representative survey. The Lancet. 2012 May 12;379(9828):1807- 16. 11. Sankaranarayanan R, Swaminathan R, Black RJ. Global variations in cancer survival. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1996 Dec 15;78(12):2461-4. 12. Crew KD, Neugut AI. Epidemiology of gastric cancer. World journal of gastroenterology: WJG. 2006 Jan 21;12(3):354. 13. Parkin DM. The evolution of the population-based cancer registry. Nature Reviews Cancer. 2006 Aug 1;6(8):603-12. 14. Herszenyi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. European Review for Medical & Pharmacological Sciences. 2010 Apr 1;14(4). 15. Cao Y, DePinho RA, Ernst M, Vousden K. Cancer research: past, present and future. Nature Reviews Cancer. 2011 Oct;11(10):749-54. 16. Boffetta P, Hashibe M. Alcohol and cancer. The lancet oncology. 2006 Feb 1;7(2):149-56. 17. Sankaranarayanan R. Screening for cancer in low-and middle-income countries. Annals of global health. 2014 Sep 1;80(5):412-7. 18. Boffetta P, Hashibe M, La Vecchia C, Zatonski W, Rehm J. The burden of cancer attributable to alcohol drinking. international Journal of Cancer. 2006 Aug 15;119(4):884-7. 19. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, Venugopal M, Anju G, Mathew BS. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. Journal of the National Cancer Institute. 2011 Oct 5;103(19):1476-80. 20. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer epidemiology, biomarkers & prevention. 2010 Aug 1;19(8):1893-907. 21. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. The lancet oncology. 2012 Aug 1;13(8):790-801.


Ahead of Print Subscription Review Article
Volume 03
02
Received 30/06/2026
Accepted 02/07/2026
Published 20/07/2026
Publication Time 20 Days


Login

My IP

PlumX Metrics

Support